Inventor

VOLKMANN ROBERT A

US66 patents

⚠️ This page may combine multiple inventors who share the name “VOLKMANN ROBERT A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VOLKMANN ROBERT A

PFIZER

Hypoglycemic thiazolidinediones

Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters

Fluoro-substituted adamantane derivatives

Polyamines and polypeptides useful as antagonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels

Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists

Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids

Process for optically active 3-thiolanyl sulfonate esters

Intermediates for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics

Intermediate diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-carboxylic acids

Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids

Process for optically active 3-thiolanyl sulfonate esters

Hypoglycemic thiazolidinediones

Polypeptides useful as blockers of calcium channels

Acyclic anc cyclic amides as neurotransmitter release enhancers

Adamantyl substituted oxindoles as pharmaceutical agents

Process for optically active 3-thiolanyl sulfonate esters

Novel process for the preparation of biotin

Process for the preparation of biotin

Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it

Process for preparing penicillanic acid 1,1-dioxide derivatives

Beta-lactamase inhibiting 6-(alkoxyamino-methyl) penicillanic acid 1,1-dioxide and derivatives

Pore forming peptides from Geolycosa riogrande

Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics

2-(1-oxo-3-thiolanyl)-2-penem antibiotics

6,6-Dihalopenicillanic acid 1,1-dioxides

6,6-dihalopenicillanic acid 1,1-dioxides and process

Beta-lactam elastase inhibitors

CADENT THERAPEUTICS INC

Thienopyrimidinone NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

Thienopyrimidinone NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

Thienopyrimidinone NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

NMDA receptor modulators and uses thereof

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B

NOVARTIS AG

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B

Thienopyrimidinone NMDA receptor modulators and uses thereof

CYBREXA 2 INC

Peptide conjugates of cytotoxins as therapeutics

Peptide conjugates of cytotoxins as therapeutics

LUC THERAPEUTICS

N-arylmethyl sulfonamide negative modulators of NR2A

CYBREXA 1 INC

Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues

LIXTE BIOTECHNOLOGY INC

Oxabicycloheptane prodrugs

CYBREXA 3 INC

Peptide conjugates of microtubule-targeting agents as therapeutics

LUC THERAPEUTICS INC

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of NR2B